{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T02:40:54Z","timestamp":1768617654754,"version":"3.49.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T00:00:00Z","timestamp":1684886400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","valueinhealthjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.jval.2023.04.012","type":"journal-article","created":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T07:05:09Z","timestamp":1684134309000},"page":"1389-1397","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Incorporating Prior Beliefs Into Meta-Analyses of Health-State Utility Values Using the Bayesian Power Prior"],"prefix":"10.1016","volume":"26","author":[{"given":"Anthony J.","family":"Hatswell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jval.2023.04.012_bib1","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.jval.2013.02.017","article-title":"Systematic searching and selection of health state utility values from the literature","volume":"16","author":"Papaioannou","year":"2013","journal-title":"Value Health"},{"issue":"suppl 1","key":"10.1016\/j.jval.2023.04.012_bib2","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s40273-017-0547-8","article-title":"The identification, review and synthesis of health state utility values from the literature","volume":"35","author":"Ara","year":"2017","journal-title":"Pharmacoeconomics"},{"issue":"9","key":"10.1016\/j.jval.2023.04.012_bib3","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1007\/s40273-018-0670-1","article-title":"A\u00a0practical guide to conducting a systematic review and meta-analysis of health state utility values","volume":"36","author":"Petrou","year":"2018","journal-title":"Pharmacoeconomics"},{"issue":"1","key":"10.1016\/j.jval.2023.04.012_bib4","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s12874-021-01292-z","article-title":"Classifying information-sharing methods","volume":"21","author":"Nikolaidis","year":"2021","journal-title":"BMC Med Res Methodol"},{"issue":"10","key":"10.1016\/j.jval.2023.04.012_bib6","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1056\/NEJMoa2004407","article-title":"Tepotinib in non\u2013small-cell lung cancer with MET Exon 14 skipping mutations","volume":"383","author":"Paik","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.jval.2023.04.012_bib7","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1177\/0272989X02238300","article-title":"A\u00a0meta-analysis of utility estimates for HIV\/AIDS","volume":"22","author":"Tengs","year":"2002","journal-title":"Med Decis Making"},{"issue":"3","key":"10.1016\/j.jval.2023.04.012_bib8","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2165\/00019053-200321030-00004","article-title":"A\u00a0meta-analysis of quality-of-life estimates for stroke","volume":"21","author":"Tengs","year":"2003","journal-title":"Pharmacoeconomics"},{"issue":"5","key":"10.1016\/j.jval.2023.04.012_bib9","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/j.1524-4733.2007.00193.x","article-title":"Quality of life assessed with the Medical Outcomes Study Short Form 36-Item Health Survey of patients on renal replacement therapy: a systematic review and meta-analysis","volume":"10","author":"Liem","year":"2007","journal-title":"Value Health"},{"issue":"4","key":"10.1016\/j.jval.2023.04.012_bib10","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/j.1524-4733.2007.00308.x","article-title":"Preference-based quality of life of patients on renal replacement therapy: a systematic review and meta-analysis","volume":"11","author":"Liem","year":"2008","journal-title":"Value Health"},{"issue":"6","key":"10.1016\/j.jval.2023.04.012_bib11","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s00198-009-0844-y","article-title":"An updated systematic review of Health State Utility Values for osteoporosis related conditions","volume":"20","author":"Peasgood","year":"2009","journal-title":"Osteoporos Int"},{"issue":"9","key":"10.1016\/j.jval.2023.04.012_bib12","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/j.jval.2020.05.014","article-title":"Health state utility values in schizophrenia: a systematic review and meta-analysis","volume":"23","author":"Aceituno","year":"2020","journal-title":"Value Health"},{"issue":"11","key":"10.1016\/j.jval.2023.04.012_bib13","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s40273-020-00947-x","article-title":"Systematic review and meta-analysis of community- and choice-based health state utility values for lung cancer","volume":"38","author":"Blom","year":"2020","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.jval.2023.04.012_bib14","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13643-015-0006-6","article-title":"Health state utility values for diabetic retinopathy: protocol for a systematic review and meta-analysis","volume":"4","author":"Sampson","year":"2015","journal-title":"Syst Rev"},{"issue":"5","key":"10.1016\/j.jval.2023.04.012_bib15","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1586\/erp.10.65","article-title":"Health-state utility values in breast cancer","volume":"10","author":"Peasgood","year":"2010","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"5","key":"10.1016\/j.jval.2023.04.012_bib16","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1002\/hec.3871","article-title":"Frequentist and Bayesian meta-regression of health state utilities for multiple myeloma incorporating systematic review and analysis of individual patient data","volume":"28","author":"Hatswell","year":"2019","journal-title":"Health Econ"},{"key":"10.1016\/j.jval.2023.04.012_bib17","unstructured":"Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions. Chichester, United Kingdom: John Wiley & Sons, Ltd. http:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/9780470712184.fmatter\/summary. Accessed June 11, 2022."},{"issue":"1","key":"10.1016\/j.jval.2023.04.012_bib19","first-page":"46","article-title":"Power prior distributions for regression models","volume":"15","author":"Ibrahim","year":"2000","journal-title":"Stat Sci"},{"issue":"2","key":"10.1016\/j.jval.2023.04.012_bib20","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1198\/108571106X110919","article-title":"Using power priors to improve the binomial test of water quality","volume":"11","author":"Duan","year":"2006","journal-title":"J\u00a0Agric Biol Environ Stat"},{"issue":"28","key":"10.1016\/j.jval.2023.04.012_bib21","doi-asserted-by":"crossref","first-page":"3724","DOI":"10.1002\/sim.6728","article-title":"The power prior: theory and applications","volume":"34","author":"Ibrahim","year":"2015","journal-title":"Stat Med"},{"issue":"7","key":"10.1016\/j.jval.2023.04.012_bib22","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1002\/sim.8019","article-title":"Modified power prior with multiple historical trials for binary endpoints","volume":"38","author":"Banbeta","year":"2019","journal-title":"Stat Med"},{"issue":"10","key":"10.1016\/j.jval.2023.04.012_bib23","first-page":"3167","article-title":"Including Historical Data in the Analysis of Clinical Trials Using the Modified Power Prior Practical Considerations for Survival Models","volume":"27","author":"Dejardin","year":"2018","journal-title":"Stat Methods Med Res"},{"issue":"5","key":"10.1016\/j.jval.2023.04.012_bib24","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1111\/rssc.12204","article-title":"A\u00a0calibrated power prior approach to Borrow information from historical data with application to biosimilar clinical trials","volume":"66","author":"Pan","year":"2017","journal-title":"J\u00a0R Stat Soc C Appl Stat"},{"issue":"4","key":"10.1016\/j.jval.2023.04.012_bib25","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1111\/rssc.12275","article-title":"Power and commensurate priors for synthesizing aggregate and individual patient level data in network meta-analysis","volume":"67","author":"Hong","year":"2018","journal-title":"J\u00a0R Stat Soc C Appl Stat"},{"issue":"28","key":"10.1016\/j.jval.2023.04.012_bib26","doi-asserted-by":"crossref","first-page":"3562","DOI":"10.1002\/sim.3722","article-title":"A\u00a0note on the power prior","volume":"28","author":"Neuenschwander","year":"2009","journal-title":"Stat Med"},{"issue":"4","key":"10.1016\/j.jval.2023.04.012_bib28","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/jrsm.1475","article-title":"On weakly informative prior distributions for the heterogeneity parameter in Bayesian random-effects meta-analysis","volume":"12","author":"R\u00f6ver","year":"2021","journal-title":"Res Synth Methods"},{"issue":"3","key":"10.1016\/j.jval.2023.04.012_bib29","first-page":"1","article-title":"Conducting meta-analyses in R with the metafor package","volume":"36","author":"Viechtbauer","year":"2010","journal-title":"J\u00a0Stat Softw"},{"key":"10.1016\/j.jval.2023.04.012_bib31","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/1477-7525-6-84","article-title":"Health state utilities for non small cell lung cancer","volume":"6","author":"Nafees","year":"2008","journal-title":"Health Qual Life Outcomes"},{"issue":"1","key":"10.1016\/j.jval.2023.04.012_bib32","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1186\/s12955-020-01559-x","article-title":"Health related quality of life utility weights for economic evaluation through different stages of chronic kidney disease: a systematic literature review","volume":"18","author":"Cooper","year":"2020","journal-title":"Health Qual Life Outcomes"},{"issue":"1","key":"10.1016\/j.jval.2023.04.012_bib33","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jval.2019.07.005","article-title":"A\u00a0systematic review and meta-analysis of health utilities in patients with chronic hepatitis C [published correction appears in Value Health. 2020;23(7):977]","volume":"23","author":"Saeed","year":"2020","journal-title":"Value Health"},{"issue":"8","key":"10.1016\/j.jval.2023.04.012_bib34","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1177\/0272989X16638312","article-title":"Analyzing health-related quality of life in the EVOLVE trial: the joint impact of treatment and clinical events","volume":"36","author":"Briggs","year":"2016","journal-title":"Med Decis Making"},{"issue":"21","key":"10.1016\/j.jval.2023.04.012_bib35","first-page":"1","article-title":"UK Mild Hepatitis C Trial Investigators. Health benefits of antiviral therapy for mild chronic hepatitis C: randomised controlled trial and economic evaluation","volume":"10","author":"Wright","year":"2006","journal-title":"Health Technol Assess Winch Engl"},{"issue":"8","key":"10.1016\/j.jval.2023.04.012_bib36","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.jval.2016.05.018","article-title":"EQ-5D scores for diabetes-related comorbidities","volume":"19","author":"Sullivan","year":"2016","journal-title":"Value Health"},{"issue":"2","key":"10.1016\/j.jval.2023.04.012_bib37","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2337\/diacare.29.02.06.dc05-1443","article-title":"The impact of patient preferences on the cost-effectiveness of intensive glucose control in older patients with new-onset diabetes","volume":"29","author":"Huang","year":"2006","journal-title":"Diabetes Care"},{"issue":"37","key":"10.1016\/j.jval.2023.04.012_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta25370","article-title":"Developing a reference protocol for structured expert elicitation in health-care decision-making: a mixed-methods study","volume":"25","author":"Bojke","year":"2021","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.jval.2023.04.012_bib39","doi-asserted-by":"crossref","unstructured":"Gosling JP. SHELF: the Sheffield elicitation framework. In: Int S Oper Res Manag Sci, Dias LC, Morton A, Quigley J, eds. Elicitation: The Science and Art of Structuring Judgement. Berlin, Germany: Springer International Publishing. 2018:61-93.","DOI":"10.1007\/978-3-319-65052-4_4"},{"issue":"2","key":"10.1016\/j.jval.2023.04.012_bib40","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jval.2013.02.002","article-title":"Consolidated health economic evaluation reporting standards (CHEERS)--explanation and elaboration: a report of the ISPOR health economic evaluation publication guidelines\u00a0good reporting practices task force","volume":"16","author":"Husereau","year":"2013","journal-title":"Value Health"},{"issue":"1","key":"10.1016\/j.jval.2023.04.012_bib41","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jval.2021.10.008","article-title":"Consolidated health economic evaluation reporting standards (CHEERS) 2022 explanation and elaboration: a report of the ISPOR CHEERS II good practices task force [published correction appears in Value Health. 2022;25(6):1060]","volume":"25","author":"Husereau","year":"2022","journal-title":"Value Health"},{"issue":"12","key":"10.1016\/j.jval.2023.04.012_bib42","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.2337\/diacare.25.12.2238","article-title":"Valuing Health-Related Quality of Life in Diabetes","volume":"25","author":"Coffey","year":"2002","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.jval.2023.04.012_bib43","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0168-8227(03)00145-1","article-title":"Subjective health values of individuals with diabetes in Japan: comparison of utility values with the SF-36 scores","volume":"62","author":"Ohsawa","year":"2003","journal-title":"Diabetes Res Clin Pract"},{"issue":"10","key":"10.1016\/j.jval.2023.04.012_bib44","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.2337\/dc07-0499","article-title":"Patient perceptions of quality of life with diabetes-related complications and treatments","volume":"30","author":"Huang","year":"2007","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.jval.2023.04.012_bib45","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.ophtha.2007.06.008","article-title":"The impact of anchor point on utilities for 5 common ophthalmic diseases","volume":"115","author":"Lee","year":"2008","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.jval.2023.04.012_bib46","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/MLR.0b013e318158af40","article-title":"Variation in Treatment Preferences and Care Goals Among Older Diabetes Patients and Their Physicians","volume":"46","author":"Chin","year":"2008","journal-title":"Med Care"}],"container-title":["Value in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301523025998?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301523025998?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T01:33:17Z","timestamp":1761096797000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098301523025998"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":42,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S1098301523025998"],"URL":"https:\/\/doi.org\/10.1016\/j.jval.2023.04.012","relation":{},"ISSN":["1098-3015"],"issn-type":[{"value":"1098-3015","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incorporating Prior Beliefs Into Meta-Analyses of Health-State Utility Values Using the Bayesian Power Prior","name":"articletitle","label":"Article Title"},{"value":"Value in Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jval.2023.04.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 International Society for Pharmacoeconomics and Outcomes Research, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}